📋 Tender Overview
The Department of Biotechnology (DBT), Government of India, conducted the fourth webinar in its Biofoundry and Biomanufacturing Initiative series today. The session focused on Biomanufacturing of Enzymes, a critical domain under the BioE3 (Biotechnology for Economy, Environment & Employment) Policy. Approved by the Union Cabinet in August 2024, the BioE3 Policy aims to position India as a global leader in bio-based innovations. It focuses on promoting sustainable biomanufacturing in thematic areas such as enzymes, smart proteins, and bio-based chemicals, supporting economic growth while ensuring environmental sustainability. The webinar provided a platform for academia, industry leaders, start-ups, and researchers to discuss advancements and opportunities in enzyme biomanufacturing--a sustainable and efficient process that replaces chemical catalysts with environmentally friendly alternatives. The discussions underscored the growing importance of enzymes in supporting innovation and reducing environmental impact across various industries.
Dr. Alka Sharma, Scientist H, DBT, highlighted the BioE3 Policys vision to foster high-performance biomanufacturing by supporting sustainable green growth. She mentioned that BioE3 Policy will set Bharat at the forefront of a future that is more sustainable and responsiveto global challenges by accelerating and harnessing biomanufacturing solutions that encompass diverse bioeconomc activities while safeguarding environmental and climate impacts. She informed that the fourth webinar in this series focuses on enzymes, a transformative vertical under the policy, stating, Enzymes are not just pivotal to advancing sustainable industrial practices but are also integral to fostering innovation, reducing environmental impact, and driving Indias bioeconomy.
Dr. Amit Kumar Yadav, Scientist D, DBT, provided an overview of the thematic sector, discussing the applications and potential of enzyme biomanufacturing in transforming industrial practices in the country. He highlighted its ability to drive sustainable practices through cost-effective and environmentally sound solutions. Dr. Syed Shams Yazdani, Group Leader, Synthetic Biology and Biofuel Group, ICGEB, New Delhi, delved into how India can position itself as a hub for industrial enzyme production. He outlined strategies to catalyze indigenous enzyme discovery, scale up manufacturing capacities, and leverage advanced technologies like synthetic biology and AI/ML to enhance microbial chassis for high-titer enzyme production.
Mr. G.S. Krishnan, President of the Association of Biotechnology Led Enterprises (ABLE), presented an industry viewpoint on the enzyme ecosystem. He discussed sourcing, production, and supply chain management and emphasized the role of local innovation. Mr. Krishnan also highlighted how the BioE3 Policy is fostering a conducive environment for long-term growth and global competitiveness in enzyme biomanufacturing. The session concluded with a vibrant Q&A segment moderated by DBT and BIRAC officials. Participants actively engaged with the experts, discussing challenges and opportunities in scaling up enzyme production and addressing regulatory considerations.
